No Data
No Data
LABIXIAOXIN: Annual Report 2024
"Performance" LABIXIAOXIN (01262.HK) narrowed its annual loss to 93.46 million yuan.
LABIXIAOXIN (01262.HK) announced its 2024 annual results, with revenue recording 0.867 billion RMB, an increase of 13.4% year-on-year. The loss narrowed from 0.105 billion yuan in the previous year to 93.46 million yuan, with a loss of 53 cents per share. No final dividend will be distributed.
Labixiaoxin Snacks Reports Revenue Growth Amid Continued Losses in 2024
LABIXIAOXIN (01262) released its annual performance report, with an annual loss of 93.5 million yuan, a year-on-year narrowing of 10.8%.
LABIXIAOXIN (01262) announced the annual performance for the year ending December 31, 2024, the group achieved...
LABIXIAOXIN: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2024
LABIXIAOXIN (01262.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.
Globe Exchange reported on March 17 that LABIXIAOXIN (01262.HK) announced that the Board of Directors will hold a meeting on March 28, 2025 (Friday) to (including) (i) approve the performance announcement for the year ending December 31, 2024, for the company and its subsidiaries; and (ii) consider the proposal for the distribution of a final dividend (if any).